Smith W Bradford
- SEC CIK
- 0001317678
No open-market purchases or sales filed in the past year.
Current role at each company
- LYRA Lyra Therapeutics, Inc.Directoras of May 15, 2026
- QTTB Q32 Bio Inc.See remarksas of Feb 27, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Smith W Bradford as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
QTTB Q32 Bio Inc.
See remarks2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2023 (view filing) | Jan 9 | 2 days | Smith W BradfordSee Remarks | SSale | −3.73K | $1.39 | −$5.18K | −20.8%14.2K after | |
| Jan 12, 2022 (view filing) | Jan 5 | 7 daysLate | Smith W BradfordCFO & Treasurer | SSale | −2.18K | $3.78 | −$8.25K | −33.1%4.42K after |